Anika Therapeutics (ANIK) Assets (2016 - 2025)
Historic Assets for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $189.4 million.
- Anika Therapeutics' Assets fell 1813.62% to $189.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.4 million, marking a year-over-year decrease of 1813.62%. This contributed to the annual value of $202.7 million for FY2024, which is 2508.65% down from last year.
- Per Anika Therapeutics' latest filing, its Assets stood at $189.4 million for Q3 2025, which was down 1813.62% from $187.7 million recorded in Q2 2025.
- Anika Therapeutics' 5-year Assets high stood at $363.1 million for Q2 2021, and its period low was $187.7 million during Q2 2025.
- In the last 5 years, Anika Therapeutics' Assets had a median value of $328.9 million in 2023 and averaged $295.5 million.
- As far as peak fluctuations go, Anika Therapeutics' Assets soared by 45.84% in 2022, and later plummeted by 2948.37% in 2024.
- Quarter analysis of 5 years shows Anika Therapeutics' Assets stood at $347.5 million in 2021, then rose by 0.46% to $349.1 million in 2022, then dropped by 22.48% to $270.6 million in 2023, then decreased by 25.09% to $202.7 million in 2024, then decreased by 6.56% to $189.4 million in 2025.
- Its Assets was $189.4 million in Q3 2025, compared to $187.7 million in Q2 2025 and $190.6 million in Q1 2025.